O Manuel

Summary

Affiliation: Centre Hospitalier Universitaire Vaudois
Country: Switzerland

Publications

  1. doi request reprint Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study
    Oriol Manuel
    Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Switzerland
    Clin Infect Dis 56:817-24. 2013
  2. pmc Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients
    Nancy Perrottet
    Microbiology Institute, University Hospital, Lausanne, Switzerland
    BMC Infect Dis 10:2. 2010
  3. doi request reprint Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation
    Oriol Manuel
    Transplantation Center, University Hospital of Lausanne CHUV, 1011 Lausanne, Switzerland
    Expert Rev Anti Infect Ther 9:955-65. 2011
  4. doi request reprint Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients
    Oriol Manuel
    Infectious Diseases Service, University Hospital Center CHUV and University of Lausanne, Lausanne, Switzerland
    J Heart Lung Transplant 30:679-84. 2011
  5. doi request reprint Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients
    Oriol Manuel
    Transplantation Center, Infectious Diseases Service, University Hospital of Lausanne CHUV and University of Lausanne, Switzerland
    Clin Infect Dis 52:248-56. 2011
  6. doi request reprint Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study
    Oriol Manuel
    Transplantation Center, University Hospital CHUV, Lausanne, Switzerland
    Clin Transplant 24:794-800. 2010
  7. doi request reprint Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards
    O Manuel
    Service of Hospital Preventive Medicine and Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    J Hosp Infect 74:326-31. 2010
  8. ncbi request reprint [Management of infection after organ transplantation by the primary care physician]
    Oriol Manuel
    Service des Maladies Infectieuses, Département de médecine et Centre de transplantation d organes, CHUV, 1011 Lausanne
    Rev Med Suisse 5:722-6. 2009
  9. doi request reprint An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants
    Oriol Manuel
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    J Infect Dis 199:1621-8. 2009
  10. ncbi request reprint Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency
    O Manuel
    Infectious Diseases Service, Transplantation Center, University Hospital, Lausanne, Switzerland
    Transpl Infect Dis 9:214-8. 2007

Collaborators

Detail Information

Publications15

  1. doi request reprint Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study
    Oriol Manuel
    Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Switzerland
    Clin Infect Dis 56:817-24. 2013
    ..CMV-specific cell-mediated immunity may be able to predict which patients will develop CMV disease...
  2. pmc Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients
    Nancy Perrottet
    Microbiology Institute, University Hospital, Lausanne, Switzerland
    BMC Infect Dis 10:2. 2010
    ..This prospective observational study aimed to correlate clinical and cytomegalovirus (CMV) viral load response (DNAemia) with ganciclovir plasma concentrations in patients treated with valganciclovir for CMV infection/disease...
  3. doi request reprint Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation
    Oriol Manuel
    Transplantation Center, University Hospital of Lausanne CHUV, 1011 Lausanne, Switzerland
    Expert Rev Anti Infect Ther 9:955-65. 2011
    ..Finally, novel strategies to further reduce the incidence of CMV disease after transplantation are also reviewed...
  4. doi request reprint Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients
    Oriol Manuel
    Infectious Diseases Service, University Hospital Center CHUV and University of Lausanne, Lausanne, Switzerland
    J Heart Lung Transplant 30:679-84. 2011
    ..In this study we compared the immunogenicity of influenza vaccine administered intradermally to the standard intramuscular vaccination in lung transplant recipients...
  5. doi request reprint Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients
    Oriol Manuel
    Transplantation Center, Infectious Diseases Service, University Hospital of Lausanne CHUV and University of Lausanne, Switzerland
    Clin Infect Dis 52:248-56. 2011
    ..We evaluated the humoral response to the influenza A H1N1/09 vaccine in solid-organ transplant (SOT) recipients, in patients with human immunodeficiency virus (HIV) infection, and in healthy individuals...
  6. doi request reprint Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study
    Oriol Manuel
    Transplantation Center, University Hospital CHUV, Lausanne, Switzerland
    Clin Transplant 24:794-800. 2010
    ..A routine daily dose of 450 mg valganciclovir appears to be acceptable for CMV prophylaxis in most kidney transplant recipients...
  7. doi request reprint Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards
    O Manuel
    Service of Hospital Preventive Medicine and Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    J Hosp Infect 74:326-31. 2010
    ..0 days, P=0.007). Patients included in the intervention group had lower antibiotic consumption than patients in the control group, but the intervention had no significant impact on the overall antibiotic consumption of the two wards...
  8. ncbi request reprint [Management of infection after organ transplantation by the primary care physician]
    Oriol Manuel
    Service des Maladies Infectieuses, Département de médecine et Centre de transplantation d organes, CHUV, 1011 Lausanne
    Rev Med Suisse 5:722-6. 2009
    ..Collaboration with the transplantation specialists is recommended in order to assure an optimal management of these patients...
  9. doi request reprint An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants
    Oriol Manuel
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    J Infect Dis 199:1621-8. 2009
    ..We studied human cytomegalovirus (CMV) donor-to-recipient transmission patterns in organ transplantation by analyzing genomic variants on the basis of CMV glycoprotein B (gB) genotyping...
  10. ncbi request reprint Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency
    O Manuel
    Infectious Diseases Service, Transplantation Center, University Hospital, Lausanne, Switzerland
    Transpl Infect Dis 9:214-8. 2007
    ..To our knowledge, this is the first report of meningococcal disease after organ transplantation in a patient with MBL deficiency...
  11. doi request reprint Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients
    D Kumar
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 9:1214-22. 2009
    ..0%) patients with a detectable interferon-gamma response (cutoff 0.1 IU/mL) versus 10/25 (40.0%) patients with a negative CMI, p = 0.12. Monitoring of CMI may be useful for predicting late-onset CMV disease...
  12. pmc Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir
    N Perrottet
    Division of Clinical Pharmacology and Toxicology Département de Médecine, Hôpital de Beaumont 06, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Antimicrob Agents Chemother 53:3017-23. 2009
    ..However, GCV plasma measurement may still be helpful in specific clinical situations...
  13. ncbi request reprint [Hepatitis B immunization in the neonate and the immunocompromised: time to resort to dedicated teams?]
    N Boillat Blanco
    Service des Maladies Infectieuses, CHUV, 1011 Lausanne
    Rev Med Suisse 8:901-4. 2012
    ....
  14. ncbi request reprint Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation
    O Manuel
    Transplant Infectious Diseases, and Microbiology, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2797-801. 2007
    ..In patients awaiting liver transplantation, both the TST and QFT-G were comparable for the diagnosis of LTBI with reasonable concordance between tests. Indeterminate QFT-G result was more likely in those with more advanced liver disease...
  15. ncbi request reprint Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients
    O Manuel
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2567-72. 2007
    ..024). After a single standard dose of influenza vaccine, a booster dose given by intradermal injection did not significantly improve vaccine immunogenicity in lung transplant recipients...